Applied StemCell Inc. (ASC) is organized around advancing gene-editing and stem cell innovation for biomedical research and the biotechnology industry. Anchored in several years of effort, the firm offers an optimized series of tools for basic research study, drug discovery, bio-processing, bio-production and preclinical applications. Currently the firm is focusing on three areas: Cell line generation for bio-production and bioassays; Patient-relevant cell models for personalized medicine and Physiologically predictive animal models of human diseases The effort is to expand the irms technologies and product lines to meet the increasing requirements of the biomedical community: disease-specific isogenic models: master cell lines for antibody/protein production; iPSCs from patients containing the corrected mutations or inserted genes for pre-clinical applications and generating animal models (mouse/rat models)
